2024–2025 BNT162b2 COVID-19 vaccine effectiveness in non-immunocompromised adults: mid-season estimates from vaccine registries in two states linked to administrative claims

Related articles

1. SARS-CoV-2 seroepidemiology, infection prevention and control practices, and occupational risks during healthcare worker reduction: a repeated cross-sectional study in Côte d'Ivoire, 2022

   This article has 9 authors:

   1. Kouassi Julien Momou
   2. Fidèle Sounan Touré
   3. Bamourou Diane
   4. Augustin Etile Anoh
   5. Pacôme Monemo
   6. Sara Tomczyk
   7. Charbel El Bcheraoui
   8. Chantal Akoua Koffi
   9. Ideswald Boone

2. Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana

   This article has 25 authors:

   1. Peter Kojo Quashie
   2. Joe Kimanthi Mutungi
   3. Francis Dzabeng
   4. Daniel Oduro-Mensah
   5. Precious C. Opurum
   6. Kesego Tapela
   7. Aniefiok John Udoakang
   8. WACCBIP COVID-19 Team
   9. Ivy Asante
   10. Lily Paemka
   11. Frederick Kumi-Ansah
   12. Osbourne Quaye
   13. Emmanuela Amoako
   14. Ralph Armah
   15. Charlyne Kilba
   16. Nana Afia Boateng
   17. Michael Ofori
   18. George B. Kyei
   19. Yaw Bediako
   20. Nicaise Ndam
   21. James Abugri
   22. Patrick Ansah
   23. William K. Ampofo
   24. Francisca Mutapi
   25. Gordon A. Awandare

   Reviewed by ScreenIT

3. Determinants of Vaccine Uptake Against Mpox Among Key Populations in Goma-drc, 2024-2025

   This article has 6 authors:

   1. Stéphane-Hans Bateyi Mustafa
   2. Tambwe Patrick
   3. Robert Biya
   4. Ngoy Shadimanga Sébastien
   5. Cizungu Safi Evelyne
   6. Michel Nzaji